Skip to main content
Top
Published in: Infection 3/2017

01-06-2017 | Case Report

Secondary haemophagocytic lymphohistiocytosis triggered by postnatally acquired cytomegalovirus infection in a late preterm infant

Authors: Christine Silwedel, Eric Frieauff, Wolfgang Thomas, Johannes G. Liese, Christian P. Speer

Published in: Infection | Issue 3/2017

Login to get access

Abstract

Haemophagocytic lymphohistiocytosis (HLH) is a hyperinflammatory condition with impairment of cytotoxic T-cells and natural killer cells. Causes in infants are mostly hereditary immune defects as well as various infectious triggering factors, amongst these cytomegalovirus (CMV). Vertical CMV transmission may occur in utero, during birth, and by breast feeding. Usually, a CMV infection transmitted via breast milk is symptomatic only in very immature preterm infants. We report on a late preterm infant born after 35 + 5 weeks of gestation with a birth weight of 1840 g, being admitted to our intensive care unit at the age of 9 weeks with acute enteritis and severe dehydration. After a prolonged recovery, the infant developed a sepsis-like condition with hyperpyrexia, hepatosplenomegaly, and pancytopenia. Combination with high ferritin levels (2809 μg/l), hypertriglyceridaemia (481 mg/dl), elevated soluble IL-2 receptor (sCD25, 9120 U/ml), and reduced perforin expression allowed diagnosis of HLH, caused by an acute CMV infection. Since connatal CMV infection had been ruled out earlier, we report the rare case of secondary HLH triggered by a postnatally acquired symptomatic CMV infection in an immunocompetent infant, most likely transmitted via breast milk. The infant was successfully treated with ganciclovir without need for immunosuppressive therapy.
Literature
2.
go back to reference Janka G, zur Stadt U. Familial and acquired hemophagocytic lymphohistiocytosis. Hematology Am Soc Hematol Educ Program. 2005:82–8. Janka G, zur Stadt U. Familial and acquired hemophagocytic lymphohistiocytosis. Hematology Am Soc Hematol Educ Program. 2005:82–8.
3.
go back to reference Henter JI, Horne A, Arico M, Egeler RM, Filipovich AH, Imashuku S, et al. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2007;48:124–31. doi:10.1002/pbc.21039.CrossRefPubMed Henter JI, Horne A, Arico M, Egeler RM, Filipovich AH, Imashuku S, et al. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2007;48:124–31. doi:10.​1002/​pbc.​21039.CrossRefPubMed
5.
go back to reference Janka G, Imashuku S, Elinder G, Schneider M, Henter JI. Infection- and malignancy-associated hemophagocytic syndromes. Secondary hemophagocytic lymphohistiocytosis. Hematol Oncol Clin N Am. 1998;12:435–44.CrossRef Janka G, Imashuku S, Elinder G, Schneider M, Henter JI. Infection- and malignancy-associated hemophagocytic syndromes. Secondary hemophagocytic lymphohistiocytosis. Hematol Oncol Clin N Am. 1998;12:435–44.CrossRef
6.
7.
go back to reference Imashuku S, Ueda I, Teramura T, Mori K, Morimoto A, Sako M, et al. Occurrence of haemophagocytic lymphohistiocytosis at less than 1 year of age: analysis of 96 patients. Eur J Pediatr. 2005;164:315–9. doi:10.1007/s00431-005-1636-9.CrossRefPubMed Imashuku S, Ueda I, Teramura T, Mori K, Morimoto A, Sako M, et al. Occurrence of haemophagocytic lymphohistiocytosis at less than 1 year of age: analysis of 96 patients. Eur J Pediatr. 2005;164:315–9. doi:10.​1007/​s00431-005-1636-9.CrossRefPubMed
8.
go back to reference Hesseling PB, Wessels G, Egeler RM, Rossouw DJ. Simultaneous occurrence of viral-associated hemophagocytic syndrome and Langerhans cell histiocytosis: a case report. Pediatr Hematol Oncol. 1995;12:135–41.CrossRefPubMed Hesseling PB, Wessels G, Egeler RM, Rossouw DJ. Simultaneous occurrence of viral-associated hemophagocytic syndrome and Langerhans cell histiocytosis: a case report. Pediatr Hematol Oncol. 1995;12:135–41.CrossRefPubMed
9.
go back to reference Olson NY, Olson LC. Virus-associated hemophagocytic syndrome: relationship to herpes group viruses. Pediatr Infect Dis. 1986;5:369–73.CrossRefPubMed Olson NY, Olson LC. Virus-associated hemophagocytic syndrome: relationship to herpes group viruses. Pediatr Infect Dis. 1986;5:369–73.CrossRefPubMed
10.
go back to reference Knorr B, Kessler U, Poschl J, Fickenscher H, Linderkamp O. A haemophagocytic lymphohistiocytosis (HLH)-like picture following breastmilk transmitted cytomegalovirus infection in a preterm infant. Scand J Infect Dis. 2007;39:173–6.CrossRefPubMed Knorr B, Kessler U, Poschl J, Fickenscher H, Linderkamp O. A haemophagocytic lymphohistiocytosis (HLH)-like picture following breastmilk transmitted cytomegalovirus infection in a preterm infant. Scand J Infect Dis. 2007;39:173–6.CrossRefPubMed
11.
go back to reference Kashiwagi Y, Kawashima H, Sato S, Ioi H, Amaha M, Takekuma K, et al. Virological and immunological characteristics of fatal virus-associated haemophagocytic syndrome (VAHS). Microbiol Immunol. 2007;51:53–62.CrossRefPubMed Kashiwagi Y, Kawashima H, Sato S, Ioi H, Amaha M, Takekuma K, et al. Virological and immunological characteristics of fatal virus-associated haemophagocytic syndrome (VAHS). Microbiol Immunol. 2007;51:53–62.CrossRefPubMed
12.
go back to reference Devecioglu O, Anak S, Atay D, Aktan P, Devecioglu E, Ozalp B, et al. Pediatric acute lymphoblastic leukemia complicated by secondary hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2009;53:491–2. doi:10.1002/pbc.22064.CrossRefPubMed Devecioglu O, Anak S, Atay D, Aktan P, Devecioglu E, Ozalp B, et al. Pediatric acute lymphoblastic leukemia complicated by secondary hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2009;53:491–2. doi:10.​1002/​pbc.​22064.CrossRefPubMed
13.
go back to reference Kanhere S, Bhagat M, Kadakia P, Joshi A, Phadke V, Chaudhari K. Hemophagocytic lymphohistiocytosis associated with cytomegalovirus infection in an immunocompetent infant: a diagnostic and therapeutic challenge! Indian J Hematol Blood Transfus. 2014;30:299–302. doi:10.1007/s12288-014-0366-4.CrossRefPubMedPubMedCentral Kanhere S, Bhagat M, Kadakia P, Joshi A, Phadke V, Chaudhari K. Hemophagocytic lymphohistiocytosis associated with cytomegalovirus infection in an immunocompetent infant: a diagnostic and therapeutic challenge! Indian J Hematol Blood Transfus. 2014;30:299–302. doi:10.​1007/​s12288-014-0366-4.CrossRefPubMedPubMedCentral
14.
go back to reference Hamprecht K, Maschmann J, Vochem M, Dietz K, Speer CP, Jahn G. Epidemiology of transmission of cytomegalovirus from mother to preterm infant by breastfeeding. Lancet. 2001;357:513–8.CrossRefPubMed Hamprecht K, Maschmann J, Vochem M, Dietz K, Speer CP, Jahn G. Epidemiology of transmission of cytomegalovirus from mother to preterm infant by breastfeeding. Lancet. 2001;357:513–8.CrossRefPubMed
15.
go back to reference Stagno S, Reynolds DW, Pass RF, Alford CA. Breast milk and the risk of cytomegalovirus infection. N Engl J Med. 1980;302:1073–6.CrossRefPubMed Stagno S, Reynolds DW, Pass RF, Alford CA. Breast milk and the risk of cytomegalovirus infection. N Engl J Med. 1980;302:1073–6.CrossRefPubMed
16.
go back to reference Neuberger P, Hamprecht K, Vochem M, Maschmann J, Speer CP, Jahn G, et al. Case–control study of symptoms and neonatal outcome of human milk-transmitted cytomegalovirus infection in premature infants. J Pediatr. 2006;148:326–31.CrossRefPubMed Neuberger P, Hamprecht K, Vochem M, Maschmann J, Speer CP, Jahn G, et al. Case–control study of symptoms and neonatal outcome of human milk-transmitted cytomegalovirus infection in premature infants. J Pediatr. 2006;148:326–31.CrossRefPubMed
17.
go back to reference Mehler K, Oberthuer A, Lang-Roth R, Kribs A. High rate of symptomatic cytomegalovirus infection in extremely low gestational age preterm infants of 22–24 weeks’ gestation after transmission via breast milk. Neonatology. 2014;105:27–32. doi:10.1159/000355306.CrossRefPubMed Mehler K, Oberthuer A, Lang-Roth R, Kribs A. High rate of symptomatic cytomegalovirus infection in extremely low gestational age preterm infants of 22–24 weeks’ gestation after transmission via breast milk. Neonatology. 2014;105:27–32. doi:10.​1159/​000355306.CrossRefPubMed
18.
go back to reference Whitley RJ, Cloud G, Gruber W, Storch GA, Demmler GJ, Jacobs RF, et al. Ganciclovir treatment of symptomatic congenital cytomegalovirus infection: results of a phase II study. National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. J Infect Dis. 1997;175:1080–6.CrossRefPubMed Whitley RJ, Cloud G, Gruber W, Storch GA, Demmler GJ, Jacobs RF, et al. Ganciclovir treatment of symptomatic congenital cytomegalovirus infection: results of a phase II study. National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. J Infect Dis. 1997;175:1080–6.CrossRefPubMed
19.
go back to reference Muller A, Eis-Hubinger AM, Brandhorst G, Heep A, Bartmann P, Franz AR. Oral valganciclovir for symptomatic congenital cytomegalovirus infection in an extremely low birth weight infant. J Perinatol. 2008;28:74–6.CrossRefPubMed Muller A, Eis-Hubinger AM, Brandhorst G, Heep A, Bartmann P, Franz AR. Oral valganciclovir for symptomatic congenital cytomegalovirus infection in an extremely low birth weight infant. J Perinatol. 2008;28:74–6.CrossRefPubMed
20.
go back to reference Acosta EP, Brundage RC, King JR, Sanchez PJ, Sood S, Agrawal V, et al. Ganciclovir population pharmacokinetics in neonates following intravenous administration of ganciclovir and oral administration of a liquid valganciclovir formulation. Clin Pharmacol Ther. 2007;81:867–72.CrossRefPubMed Acosta EP, Brundage RC, King JR, Sanchez PJ, Sood S, Agrawal V, et al. Ganciclovir population pharmacokinetics in neonates following intravenous administration of ganciclovir and oral administration of a liquid valganciclovir formulation. Clin Pharmacol Ther. 2007;81:867–72.CrossRefPubMed
21.
go back to reference Frenkel LM, Capparelli EV, Dankner WM, Xu J, Smith IL, Ballow A, et al. Oral ganciclovir in children: pharmacokinetics, safety, tolerance, and antiviral effects. The Pediatric AIDS Clinical Trials Group. J Infect Dis. 2000;182:1616–24.CrossRefPubMed Frenkel LM, Capparelli EV, Dankner WM, Xu J, Smith IL, Ballow A, et al. Oral ganciclovir in children: pharmacokinetics, safety, tolerance, and antiviral effects. The Pediatric AIDS Clinical Trials Group. J Infect Dis. 2000;182:1616–24.CrossRefPubMed
Metadata
Title
Secondary haemophagocytic lymphohistiocytosis triggered by postnatally acquired cytomegalovirus infection in a late preterm infant
Authors
Christine Silwedel
Eric Frieauff
Wolfgang Thomas
Johannes G. Liese
Christian P. Speer
Publication date
01-06-2017
Publisher
Springer Berlin Heidelberg
Published in
Infection / Issue 3/2017
Print ISSN: 0300-8126
Electronic ISSN: 1439-0973
DOI
https://doi.org/10.1007/s15010-016-0970-3

Other articles of this Issue 3/2017

Infection 3/2017 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.